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INTRODUCTION
In-vitro fertilization (IVF) is a technique which
offers a possibility for fertilization to infertile couples
and has been used world-wide for aiding infertile
couples with tubal blockage. However, the tech-
nique is not effective for severe oligozoospermic
patients because few spermatozoa of the patients
can penetrate the zonae pellucidae. For more than
a decade, the fertilization failure of spermatozoa
from oligozoospermic patients was one of the most
important problems to be solved for improving the
pregnancy rate of oligozoospermic patients. The
appearance of intra-cytoplasmic sperm injection
(ICSI) dramatically improved the fertilization and
pregnancy rates of oligozoospermic patients and
ICSI showed that penetration of spermatozoa
through the zonae pellucidae and fusion between
a sperm cell membrane and oolenma are not essen-
tial for early development of embryos (1). However,
fertilization failure still occurs in ICSI (1-3). Approxi-
mately 80% of unfertilized oocytes following ICSI
contain a spermatozoon (4). This suggests that the
process from meiosis to mitosis was impaired in the
unfertilized oocytes and the fertilization failure is
defined as failure of the M-G1 transition in metaphase
II (MII) oocytes. The failure of the M-G1 transition
may be repaired by artificial oocyte activation.
In this review, we discuss the possible treatment
for failure of the M-G1 transition in MII oocyte.
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FAILURE OF OOCYTE ACTIVATION IN ICSI
In mammals, except dogs and foxes, oocytes which
are ovulated from ovaries are arrested at M II and
they contain a high level of maturation (or M-phase)
promoting factor (MPF : the universal regulator of
the G 2-M transition in eukaryotic cells, which con-
sists of cdc2 kinase and cyclin B). Cytostatic factor
(CSF), which stabilizes MPF activity is also kept
high in MII oocytes (5). When one spermatozoon
contacts the oolenma or penetrates into the ooplasm,
calcium oscillation occurs (6-8). The mechanism
that induces calcium oscillation in ooplasm remains
unknown. However the success of ICSI strongly
suggests that a factor which induces calcium oscilla-
tion in ooplasm (so called oscillin) is present in sper-
matozoa and is directly introduced into the ooplasm,
not via a sperm receptor (4). Calmodulin-dependent
kinase II (CaM KII) is activated by a Ca2+ transient
and the activation of the kinase probably turns on
the cyclin degradation machinery, resulting in cyclin
B degradation and sister chromatid separation (9)
(Fig.1). The process of M-G1 transition in MII oocytes
is called“oocyte activation”. In in vitro fertilization
(IVF) 5̃32% of unfertilized oocytes have a sperma-
tozoon in the ooplasm (10-15). This suggests that at
least two-thirds of spermatozoa, which penetrate
oocytes possesses an ability to activate MII oocytes.
ICSI is the most efficient and widely accepted
treatment for aiding severe oligozoospermic patients,
a group of azoospermic patients and patients who
experienced previous fertilization failure using con-
ventional IVF and embryo transfer (ET) treatment.
The overall fertilization rate by ICSI is between 50%
and 70% (1-3). In contrast to IVF, approximately 80%
of unfertilized oocytes which have no signs of acti-
vation following ICSI have a spermatozoon in their
ooplasm, and in the majority of these oocytes, the
sperm head was partially or completely decondensed
(4). Many studies have suggested that failure of
oocyte activation is the principal cause of fertiliza-
tion failure in ICSI (15-17). Even spermatozoa with
abnormal morphology and elongated spermatids
have an ability to activate oocytes similar to normal
mature spermatozoa. Considering these findings,
cell membranes of spermatozoa which fuse to
oolenma during normal fertilization still remain in
the ooplasm and may interfere with the migration of
oscillin into ooplasm at the proper time, resulting
in failure of oocyte activation. Recently, Yanagida
et al , reported that in 0.9% of ICSI cases with motile
spermatozoa, the motile spermatozoa failed to fer-
tilize the oocytes despite an apparently successful
ICSI procedure (18). Futhermore, in patients with
round-headed sperm the fertilization rate following
ICSI was extremely low compared with patients
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Fig.1. Model for the mechanisms of metaphase II arrest and release in vertebrate eggs. Fertilization triggers the activation of
calmodulin-dependent kinase II via a Ca2+ transient, which probably activates the cyclin degradation machinery, resulting in cyclin
B degradation and sister chromatid separation (Sagata, 1996)
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with other types of male infertility due to the absence
of oocyte activation capacity (19, 20). If unfertilized
oocytes after ICSI are properly activated, they may
form two pronuclei with extrusion of the second
polar body, and cleave and develop normally. Indeed,
oocytes injected with a spermatozoon unable to
fertilize MII oocytes were immediately activated
with electric pulse or calcium ionophore A23187.
Consequently, successful pregnancies were achieved
and two healthy babies were born (18, 20). The ac-
tivation methods they used produced two pronuclei
with extrusion of the second polar body in oocytes
with a spermatozoon. This suggests that the activa-
tion method which produces one pronucleus with
extrusion of the second polar body in oocytes with-
out a spermatozoon is necessary for producing
embryos with normal karyotypes.
OOCYTE ACTIVATION WITH CALCIUM
IONOPHORE A23187 AND PUROMYCIN
There are many physical and chemical stimuli
for inducing parthenogenetic or oocyte activation
in mammals, such as ethanol (21, 22), calcium
ionophore A23187 (Ca ionophore) (23, 24), inhib-
itors of protein synthesis (25, 26) and electric pulse
(24, 27-29). Mouse aged oocytes are easily activated
at a consistently high rate by Ca ionophore or
ethanol which induce a calcium transient in the
ooplasm (30). In contrast to mouse oocytes, Ca
ionophore does not effectively activate human aged
oocytes (31, 32). In general, human aged oocytes
are less sensitive to widely used stimuli like Ca
ionophore and ethanol than mouse aged oocytes.
However, puromycin, an inhibitor of protein syn-
thesis, produces parthenogenones in about 90% of
human oocytes (31, 33, 34). However, 77% of the
human parthenogenones activated by puromycin
possessed 2 haploid pronuclei or 1 diploid pronucleus
without extrusion of the second polar body (34).
Moses and Masui showed that 6-dimethylaminopurine
(6-DMAP)-an analogue of puromysin-suppressed
extrusion of the second polar body in mouse oocytes
(35). As mentioned above, an increase in intra-
cellular Ca concentration and MPF inactivation are
the main molecular events of M-G1 transiton in
MII oocytes and to mimic these events, human aged
unfertilized oocytes following IVF were activated
using various combinations of Ca ionophore and
puromycin or 6-DMAP. When oocytes activated
with 5 µM calcium ionophore A23187 (Sigma, St.
Louis, Mo, USA) for 5 minutes were incubated in
HTF medium containing 10µg/ml puromycin (Sigma,
St. Louis, Mo, USA) for 5 hours, the activation rate
was approximately 90%, which is similar to the rates
reported by De Sutter et al. (33, 34) and Balakier
et al. (31). Furthermore, in approximately 80% of
the activated oocytes, one pronucleus was formed
with extrusion of the second polar body (Fig 2).
However, when oocytes were treated with Ca
ionophore and 6-DMAP, they did not extrude the
second polar body. In the next experiment, the
activated oocytes displaying one pronucleus with
extrusion of the second polar body were cytogeneti-
cally analysed. Cytogenetical analysis showed a normal
haploid set of chromosomes in 78% of the activated
oocytes. These findings suggested that the activated
oocytes displaying one pronucleus with extrusion of
the second polar body were haploid. If unfertilized
oocytes with a spermatozoon are activated with a
combination of Ca ionophore and puromycin, the
activated oocytes should possess two pronuclei -one
female and one male pronuclei- with extrusion of
the second polar body similar to normal fertilized
Fig.2. The activation rate, proportion of parthenogenones
displaying one pronucleus with extrusion of the second polar
body and cleavage rate in human aged oocytes activated by
calcium ionophore and protein phosphorylation inhibitors.
Human aged unfertilized oocytes activated with 5 µM calcium
ionophore A23187 for 5 minutes were incubated in HTF medium
containing 10 µg/ml puromycin for 5 hours. After incubation for
13 hours, the oocytes were examined using an inverted micro-
scope with Nomarski interference phase-contrast optics.“Activated
oocytes”were defined as oocytes with at least one pronucleus
or that had immediately cleaved.
*p<0.05 : puromycin and 6-DMAP vs control
**p<0.05 : puromycin vs 6-DMAP and control
***P<0.05 : 6-DMAP vs puromycin and control
■ activation rate
proportion of 1PN2PB
parthenogenones
□ cleavage rate
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oocytes. In our preliminary study, when unfertilized
oocytes following ICSI were treated with Ca
ionophore and puromycin, two pronuclei and the
second polar body appeared in 30% of the oocytes
18 hours after treatment with Ca ionophore. Seventy
percent of the activated oocytes developed as far
as the 8-cell stage 42 hours after the Ca ionophore
treatment and in cytogenetical analysis all cleaved
parthenogenones (n=4) showed normal karyotypes.
However, whether one of the appeared pronuclei was
derived from a spermatozoa or not remains unknown.
The sex ratio of the cleaved parthenogenones
should be determined to clarify this, because half
of the cleaved parthenogenones must have Y chromo-
somes if the genome derived from a spermatozoa
is normally involved in the early development.
Young oocytes are not easily activated by a
calcium transient. Kubiak et al . (22) and Vincent et
al. (36) reported that mouse young oocytes activated
with Ca ionophore or 7% ethanol did expel a second
polar body, but became arrested again at so-called
metaphase III (MIII), in which unichromatid chro-
mosomes were scattered in misshapen microtuble
spindles. However, 6-DMAP induced mouse young
oocytes that were activated with Ca ionophore, but
arrested at MIII, to enter interphase (35). In the
present study, when mouse young oocytes were
exposed to 5 µM Ca ionophore and incubated in a
medium containing 10 µg/ml puromycin for 4 hours,
the activation rate was 90%. More than 80% of the
activated oocytes showed one pronucleus with ex-
trusion of the second polar body (Table 1, Fig. 3).
These findings are similar to those of human aged
oocytes. Futhermore, the DNA content of the
pronucleus of the activated oocytes was half the
DNA content of a set of MII chromosomes and the
most highly activated oocytes possessed 20 chro-
mosomes (normal haploid set). In conclusion, a
combination of Ca ionophore and puromycin pro-
duced haploid parthenogenones in young mouse
oocytes. This strongly suggests that the combination
is effective for inducing haploid parthenogenones
from young human oocytes although we did not
activate human young oocytes in the present study.
MOLECULAR EVENTS INDUCED BY CALCIUM
IONOPHORE AND PUROMYCIN
It is unknown how the combination of Ca ionophore
and puromycin produces parthenogenones display-
ing one pronucleus with extrusion of the second
Fig.3. Parthenogenone diaplaying one pronucleus with extrusion
of the second polar body. arrow : the second polar body, arrow
head : pronucleus
Table 1. Effect of calcium ionophore and/or protein phosphorylation inhibitors on oocyte activation of mouse young oocytes.
Activated oocytes (%)
No. of oocytes treated Total No. of activated
oocytes (%)
No. of parthenogenones
with 1PN2PB (%)
Ca ionophore (+)
Control
Puromycin
DMAP
90
116
93
8 ( 8.9)
103*(88.8)
41 (44.1)
3 ( 3.3)
94*(81.0)
28 (30.1)
*p<0.0001 (the puromycin group vs the control and DMAP groups)
PN : pronucleus
PB : polar body
DMAP : 6-dimethylaminopurine
Activated oocytes means oocytes which had formed at least one pronucleus.
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polar body. A Ca2+ transient induced by the Ca
ionophore must trigger the M-G1 transition. Rinaudo
et al . reported that human oocytes exposed to Ca
ionophore exhibited an isolated elevation of intra-
cellular calcium concentration, followed by a prompt
return to baseline levels (32). A Ca2+ transient ac-
tivates calmodulin-dependent kinase II (CaM KII),
which probably turns on the cyclin degradation
machinery, resulting in cyclin B degradation and
sister chomatid separation (9). In the present study
a Ca2+ transient induced by Ca ionophore probably
inactivated MPF activity via CaM KII. However, a
Ca2+ wave could be a positive signal that activates
myosin light chain kinase (37). This kinase is ac-
tivated through the Ca2+/calmoduline complex and
activates the contractile ring which consists of actin
and myosin in cytokinesis. The extrusion of the
second polar body is an uneven cleavage of the cell.
A Ca2+ transient induced by Ca ionophore might
play an important role of extruding the second
polar body.
In our experiments, 25̃50% of oocytes activated
by Ca ionophore alone extruded the second polar
body without formation of a pronucleus (M III
stage). Cotreatment with puromycin increased the
rate of oocytes with a pronucleus or pronuclei to
approximately 90%. Verlhac et al, reported that
when freshly ovulated MII mouse oocytes were
treated with ethanol, MPF activity dropped to one
fourth at the time of polar body extrusion and this
activity increased again in MIII oocytes to a level
slightly lower than that observed in MII oocytes (38).
MPF activity of MIII oocytes might have inceased
again in the present study. Puromycin and 6 -DMAP
are known to inhibit mitogen activating protein
kinase (MAPK) which is a component of CSF in
mouse (39) and bovine oocytes (40). Sagata reported
that MAPK probably activates a positive regulator
of MPF (e.g. cdc 25) or inhibits negative regulators
(e.g. weel or proteinphosphatase 2 A) (9). So, this
suggests that puromycin decreased MPF activity
via suppression of MAPK, resulting in the formation
of a pronucleus.
Cotreatment with 6 -DMAP completely suppressed
extrusion of the second polar body in human aged
oocytes, but not cotreatment with puromycin. This
finding agrees with the study by Liu et al. (41)
that the combination of Ca ionophore and 6 -DMAP
disrupted the oocyte spindle and effectively produced
parthenogenones diaplaying one pronucleus without
extrusion of the second polar body. However, treat-
ment of puromycin without Ca ionophore produces
parthenogenones displaying 2 haploid pronuclei or
1 diploid pronucleus without extrusion of the second
polar body. It is unkown how the combination of
Ca ionophore and puromycin can extrude the second
polar body. Some molecular events provoked by
the Ca ionophore might be suppressed by 6 -DMAP,
but not puromycin, resulting in suppression of ex-
trusion of the second polar body.
A major difference between puromycin and 6-DMAP
is that puromycin inhibits protein synthesis, while
6-DMAP does not. Rime et al. (42) reported that
puromycin provokes a approximate 60% decrease
in protein synthesis together with the formation of
a pronucleus. However, the emission of the second
polar body does not appear to be attributed to the
inhibition of protein synthesis.
CLINICAL ADAPTATION OF THE OOCYTE
ACTIVATION
Clinical adaptation of this method may be possible,
but it is still far from reality at present. Prior to the
clinical adaptation, the safety of rescuing unferti-
lized oocytes and the cytotoxic, teratogenetic and
mutagenetic activity of Ca ionophore and puromycin
should be approved. Many cytogenetical analyse
show that approximately 25% of unfertilized oocytes
following IVF have chromosomal aberrations (11,
14, 15, 43, 44, 45-47). Pickering et al . reported that
aged unfertilized oocytes (24̃48 h) displayed a
higher incidence (approximately 30%) of disrupted
or abnormal spindles (48). Furthermore, Dozortsev
recently reported that swollen nuclei with frag-
mented pieces of chromosomes were observed in
51% of unfertilized oocytes after ICSI and these
probably corresponded to degenerating nuclei (16).
If unfertilized oocytes are evenly activated with Ca
ionophore and puromycin, activated oocytes with
chromosomal aberrations and/or swollen nuclei
with fragmented pieces of chromosomes must be
discarded. However, in the present study approxi-
mately 80% of oocytes, which had been unfertilized
after IVF, showed a normal haploid set of chro-
mosomes after activation. This may suggest that MII
oocytes respondent to Ca ionophore and puromycin
have 23 chromosomes with 2C and have an ability
to finish meiosis. In respect to organelles other
than chromosomes, Sousa and Tesarik reported
that no obvious ultrastructual signs of degeneration
(vacuolation, mitchondrial swelling) were apparent
in any of 15 oocytes that failed to fertilize by 44 h
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after ICSI although the functions of organelles in
the oocytes remain unknown (49).
In ICSI cases with spermatozoa unable to fertilize
oocytes, successful pregnancies were achieved
using a combination of ICSI and oocyte activation
(18, 19). Young oocytes are difficult to activate
because the activities of MPF and MAPK are stable.
However, in mice, 90% of newly ovulated oocytes
were activated with Ca ionophore and puromycin
and approximately 80% of the activated oocytes
showed one pronucleus with extrusion of the second
polar body. This suggests that the combination of
Ca ionophore and puromycin is effective for activa-
ting young human oocytes. In cases of activating
young oocytes, the adverse effects of aging on
oocyte quality was not found to be an important
consideration.
Ca ionophore A23187 does not appear to be
cytotoxic to oocytes if the concentration is low (50).
Indeed, in mice, oocytes activated by Ca ionophore
developed as far as the post-implantation stage. If
oocytes survive an isolated elevation of intracellular
calcium concentration induced by Ca ionophore,
the activated oocytes with a diploid set of chromo-
somes developed as far as the post-implantation
stage. However, these parthenogenones do not
have a paternal genome and some genes like the
igf2 gene are not expressed because of genomic
imprinting. So, the ability to develop as far as the
post-implantation stages does not mean that the
genes are normal. Further studies are required to
approve the safety of Ca ionophore, although a
healthy baby was born after treatment with Ca
ionophore.
A high dosage and/or prolonged treatment with
puromycin can irreversibly damage the chromosomes
(pulverization, breakage), but not a low dosage and
a short treatment (33). Indeed, in the present human
and mouse cytogenetical analysis, 70̃80% of oocytes
activated with Ca ionophore and puromycin showed
a normal haploid set of chromosomes with normal
morphology. Bovine oocytes activated with Ca
ionophore and 6-DMAP developed to the blastocyst
and hatched blastocyst stages similar to those
derived from IVF-ET (41). These findings suggest
that inhibition of MAPK activity do not appear to
affect the developmental abilty of embryos.
At present there are no methods to select fresh
normal embryos. By culturing embryos to the
blastocyst stage, genetically abnormal embryos may
be selected out through aberrations in their de-
velopment (51) and may produce the most viable
embryos without abnormal organelles. However,
the ability to develop as far as the post-implantation
stages does not indicate the genes are developing
normally. At present, the teratogenetic and muta-
genetic activity of Ca ionophore and puromycin
are under investigation in our center using a mouse
model.
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